Treatment of larva migrans syndrome with long-term administration of albendazole

Beaver, 1952, Chronic eosinophilia due to visceral larva migrans, report of three cases, Pediatrics, 9, 7, 10.1542/peds.9.1.7 Maruyama, 1996, An outbreak of visceral larva migrans due to Ascaris suum in Kyushu, Japan, Lancet, 347, 1766, 10.1016/S0140-6736(96)90844-2 Hamilton, 2014, Toxocariasis, 425 U.S. Department of Health & Human Services, Center for Disease Control and Prevention. Toxocariasis. http://www.cdc.gov/parasites/toxocarosis/health_professionals/2014/5/28. Woodhall, 2013, Toxocariasis: a review for pediatricians, J Pediatr Infect Dis Soc, 1 Akao, 2007, Toxocarosis in Japan, Parasitol Int, 56, 87, 10.1016/j.parint.2007.01.009 Despommier, 2003, Toxocarosis: clinical aspects, epidemiology, medical ecology, and molecular aspects, Clin Microbiol Rev, 16, 265, 10.1128/CMR.16.2.265-272.2003 Fan, 2013, Factors affecting disease manifestation of toxocarosis in humans: genetics and environment, Veterinary Parasitol, 193, 342, 10.1016/j.vetpar.2012.12.030 Magnaval, 2001, Highlights of human toxocarosis, Korean J Parasitol, 39, 1, 10.3347/kjp.2001.39.1.1 Magnaval, 2006, Management and treatment options for human toxocariasis, 113 Hossack, 2008, A case of adult hepatic toxocariasis, Nat Clin Pract Gastroenterology Hepatology, 5, 344, 10.1038/ncpgasthep1140 Ranasuriya, 2014, Pulmonary Toxocariasis: a case report and literature review, Infection, 42, 575, 10.1007/s15010-014-0587-3 Pawlowski, 2001, Toxocariasis in humans: clinical expression and treatment dilemma, J Helminthol, 75, 299, 10.1017/S0022149X01000464 Sturchler, 1989, Thiabendazole vs. albendazole in treatment of toxocariasis: a clinical trial, Ann Trop Med Parasitol, 83, 473, 10.1080/00034983.1989.11812374 Yoshikawa, 2010, Toxocariasis Canis, toxocariasis cati. Treatment manual for parasitic diseases, Res Group Chemother Trop Dis Jpn Guidel drug Parasit Infect, 71 Yoshida, 2016, Larva migrans syndrome caused by Toxocara and Ascaris roundworm infections in Japanese patients, Eur J Clin Microbiol Infect Dis, 35, 1521, 10.1007/s10096-016-2693-x Horton, 2000, Albendazole: a review of anthelmintic efficacy and safety in humans, Parasitology, 121, S113, 10.1017/S0031182000007290 Deshayes, 2016, Neurotoxocariasis: a systematic literature review, Infection, 44, 565, 10.1007/s15010-016-0889-8 Kuenzli, 2016, Toxocariasis-associated cardiac diseases–a systematic review of the literature, Acta Trop, 154, 107, 10.1016/j.actatropica.2015.11.003 Seong, 2014, A case of ocular toxocariasis successfully treated with albendazole and triamcinolon, Korean J Parasitol, 52, 537, 10.3347/kjp.2014.52.5.537 2013, Drugs for parasitic infections, Treat Guidel Med Lett, 11, e23 Barisani-Asenbauer, 2001, Treatment of ocular toxocariasis with albendazole, J Ocular Pharmacol Ther, 17, 287, 10.1089/108076801750295317 Singh, 2007, Detection and treatment of ocular toxocariasis, Rev Ophthalmol, 14, 55 Izumikawa, 2011, Eosinophilic pneumonia due to visceral larva migrans possibly caused by Ascaris suum: a case report and review of recent literatures, Jpn J Infect Dis, 64, 428, 10.7883/yoken.64.428 United States National Library of Medicine. Clinical and Research Information on Drug-Induced Liver Injury. https://livertox.nlm.nih.gov/Albendazole.htm2016/8/25. Magnaval, 1998, Apparent weak efficacy of ivermectin for treatment of human toxocariasis, Antimicrob Agents Chemother, 42, 2770, 10.1128/AAC.42.10.2770